FDA OKs Emergent’s mPox Vaccine
The Dermatology Digest
AUGUST 30, 2024
The approval is based on previously available human safety data and data from a well-controlled animal study in which ACAM2000 vaccine was shown to be effective in protecting against mpox virus exposure. In 2022, the world experienced a global outbreak of clade II mpox, which led to more than 95,000 cases across 115 non-endemic countries.
Let's personalize your content